Mark Cuban Cost Plus Drug Company aims to disrupt pharmaceutical pricing by offering a biosimilar version of Stelara, a popular drug by Johnson & Johnson, potentially making the treatment more affordable for patients.
Back
Stat
Next Post
How Private Clubs Are Becoming Launchpads for New Ventures
Related Posts
Customer Expectations Held Flat for Eleven Years. Patience Ran Out.
The American Customer Satisfaction Index read 76.1 in August 2026, the same score it held in 2015, so United States customer expectations have held flat for eleven years while complaints hit records and the variable that actually moved was tolerance.
Read More
How Enterprise Marketing Teams Are Using Neuromarketing Research to Win in Regulated Categories
TLDR: Regulated-industry marketers who build neuromarketing capabilities at pre-launch stage convert compliance...
Read More